Lantern Pharma Inc. (LTRN)

AI Score

Unlock

3.63

-0.10 (-2.68%)

At close: Apr 24, 2025, 11:33 AM

Lantern Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	7.51M	8.1M	12.98M	18.36M	21.94M	25.57M	28.42M	32.48M	37.2M	39.26M	43.36M	46.65M	51.52M	54.67M	61.35M	81.37M	19.23M	20.8M	23.8M	634.25K	1.23M	-445.16K
Short-Term Investments	16.5M	19.95M	20.29M	20M	19.36M	19.35M	19.53M	19.06M	17.99M	18.57M	18.79M	18.56M	19.2M	19.16M	18.23M	n/a	n/a	n/a	n/a	n/a	n/a	890.33K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	541.18K	541.18K	1M	1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	36.74K	36.74K	32.02K	25.87K	25.87K	25.87K	25.87K	32.97K	17.89K	17.89K	17.89K	17.89K	17.89K	17.89K	17.89K	n/a	101.2K	n/a	n/a	263.38K	191K	-445.16K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-305K	-339K	-228K	-181K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.23M	1.87M	2.03M	1.11M	1.61M	2.5M	3.09M	2.1M	541.18K	3.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.67M	1.73M	n/a	n/a	n/a
Total Current Assets	25.25M	29.92M	35.29M	39.47M	43.34M	47.43M	51.04M	55.17M	58.72M	62.02M	65.66M	67.66M	72.72M	76.34M	82.13M	82.48M	20.24M	22.48M	25.6M	766.39K	1.23M	445.16K
Property-Plant & Equipment	287.43K	335.57K	263.34K	237.49K	280.42K	319.66K	358.2K	308.79K	95.69K	126.73K	157.75K	180.29K	216.19K	251.67K	283.1K	20.16K	21.51K	17.61K	15.38K	8.22K	8.76K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	324.16K	372.3K	295.35K	263.36K	306.29K	345.53K	384.07K	341.75K	113.58K	144.62K	716.82K	739.36K	1.23M	1.27M	300.99K	20.16K	122.71K	17.61K	15.38K	271.6K	199.76K	-445.16K
Total Assets	25.57M	30.29M	35.59M	39.73M	43.65M	47.77M	51.43M	55.51M	58.84M	62.16M	66.38M	68.4M	73.95M	77.61M	82.43M	82.5M	20.36M	22.49M	25.61M	1.04M	1.43M	n/a
Account Payables	n/a	n/a	4.44M	1.61M	942.21K	2.09M	2.85M	1.19M	n/a	985.97K	2.02M	690.65K	681.11K	722.64K	1.09M	664.53K	432.34K	805.56K	467.99K	439.26K	478.29K	n/a
Deferred Revenue	n/a	n/a	-4.44M	-3.78M	-1.74K	-2.09M	-2.85M	-2.67M	n/a	-3.05M	-5.17B	-2.92M	-2.33B	-1.64M	n/a	n/a	n/a	n/a	n/a	-439.26K	n/a	n/a
Short-Term Debt	n/a	n/a	164K	n/a	n/a	168.01K	163.15K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	102.83K	53.27K	n/a	n/a
Other Current Liabilities	4.14M	3.4M	-164K	2.16M	1.56M	-168.01K	-163.15K	1.49M	2.75M	2.06M	3.16M	2.23M	1.49M	914K	n/a	n/a	n/a	-9K	1.71M	-9K	2K	n/a
Total Current Liabilities	4.33M	3.6M	4.6M	3.95M	2.68M	2.25M	3.02M	2.79M	2.8M	3.14M	5.3M	3.07M	2.33M	1.79M	2.69M	664.53K	552.34K	814.56K	2.28M	501.53K	489.29K	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	108.5K	108.5K	108.5K	108.5K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	52.84K	93.95K	54.69K	15.56K	61.49K	106.52K	150.71K	140.63K	n/a	92.02K	5.3M	13.3K	52.89K	92.02K	130.71K	108.5K	108.5K	108.5K	108.5K	n/a	n/a	n/a
Total Liabilities	4.38M	3.7M	4.66M	3.97M	2.74M	2.36M	3.17M	2.93M	2.8M	3.14M	5.3M	3.09M	2.38M	1.88M	2.82M	773.03K	660.84K	923.06K	2.39M	501.53K	489.29K	n/a
Total Debt	243.66K	291.24K	218.7K	193.58K	234.47K	274.53K	313.86K	260.22K	52.89K	92.02K	130.71K	168.49K	204.95K	240.98K	276.6K	108.5K	108.5K	108.5K	211.33K	53.27K	n/a	n/a
Common Stock	1.08K	1.08K	1.08K	1.08K	1.07K	1.09K	1.09K	1.09K	1.09K	1.09K	1.08K	1.08K	1.11K	1.12K	1.12K	1.12K	622.00	622.00	622.00	117.00	11.37K	n/a
Retained Earnings	-76.03M	-70.15M	-65.64M	-60.69M	-55.24M	-51.06M	-47.9M	-43.15M	-39.28M	-35.9M	-33.64M	-29.14M	-25.02M	-21.48M	-17.43M	-15.11M	-12.66M	-9.76M	-8.06M	-7.23M	-6.75M	n/a
Comprehensive Income	153.99K	-25.26K	-6.58K	1.86K	-107.46K	-138.79K	-261.84K	-299.68K	-371.39K	-435.04K	-348.48K	-311.47K	-92.69K	-102.69K	-47.56K	0.00	-0.00	-0.00	-0.00	n/a	n/a	-209.23K
Shareholders Equity	21.19M	26.6M	30.93M	35.77M	40.91M	45.41M	48.26M	52.58M	56.04M	59.03M	61.08M	65.32M	71.57M	75.73M	79.61M	81.73M	19.7M	21.57M	23.23M	536.47K	943.28K	-201.8K
Total Investments	16.5M	19.95M	20.29M	20M	19.36M	19.35M	19.53M	19.06M	17.99M	18.57M	18.79M	18.56M	19.2M	19.16M	18.23M	n/a	n/a	n/a	n/a	n/a	n/a	890.33K